Moderate to Severe Chronic Spontaneous Urticaria research hub

A Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study Evaluating the Efficacy and Safety of EVO756 in Adults with Moderate to Severe Chronic Spontaneous Urticaria.

This study looks at a new medicine called EVO756 for adults with ongoing, severe hives (urticaria). It aims to see if different doses are safe and help reduce itching and rash better than a dummy treatment.